State Street’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $114M | Buy |
|
|||||
|
2025
Q2 | $67.8M | Sell |
|
|||||
|
2025
Q1 | $48.2M | Buy |
|
|||||
|
2024
Q4 | $67.9M | Sell |
|
|||||
|
2024
Q3 | $81.8M | Sell |
|
|||||
|
2024
Q2 | $57M | Sell |
|
|||||
|
2024
Q1 | $107M | Buy |
|
|||||
|
2023
Q4 | $48.2M | Sell |
|
|||||
|
2023
Q3 | $27.6M | Sell |
|
|||||
|
2023
Q2 | $60.2M | Sell |
|
|||||
|
2023
Q1 | $80.8M | Sell |
|
|||||
|
2022
Q4 | $71M | Buy |
|
|||||
|
2022
Q3 | $58.5M | Sell |
|
|||||
|
2022
Q2 | $69.2M | Buy |
|
|||||
|
2022
Q1 | $88.6M | Buy |
|
|||||
|
2021
Q4 | $104M | Buy |
|
|||||
|
2021
Q3 | $84.6M | Buy |
|
|||||
|
2021
Q2 | $64.8M | Buy |
|
|||||
|
2021
Q1 | $36.4M | Buy |
|
|||||
|
2020
Q4 | $9.95M | Buy |
|